These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29371602)

  • 21. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake.
    Timmermans AD; Balteau M; Gélinas R; Renguet E; Ginion A; de Meester C; Sakamoto K; Balligand JL; Bontemps F; Vanoverschelde JL; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2014 Jun; 306(12):H1619-30. PubMed ID: 24748590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy.
    Hu C; Zhang H; Qiao Z; Wang Y; Zhang P; Yang D
    Exp Cell Res; 2018 Nov; 372(1):61-72. PubMed ID: 30236513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway.
    Ishikita A; Matsushima S; Ikeda S; Okabe K; Nishimura R; Tadokoro T; Enzan N; Yamamoto T; Sada M; Tsutsui Y; Miyake R; Ikeda M; Ide T; Kinugawa S; Tsutsui H
    iScience; 2021 Dec; 24(12):103517. PubMed ID: 34934932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
    J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMPK attenuates microtubule proliferation in cardiac hypertrophy.
    Fassett JT; Hu X; Xu X; Lu Z; Zhang P; Chen Y; Bache RJ
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H749-58. PubMed ID: 23316058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
    Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
    J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
    Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
    Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
    Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
    Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
    PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The AMPK gamma1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes.
    Folmes KD; Witters LA; Allard MF; Young ME; Dyck JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3456-64. PubMed ID: 17906100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.
    Gao M; Hu F; Hu M; Hu Y; Shi H; Zhao GJ; Jian C; Ji YX; Zhang XJ; She ZG; Li H; Zhu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32964914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy.
    Roe ND; Xu X; Kandadi MR; Hu N; Pang J; Weiser-Evans MC; Ren J
    Biochim Biophys Acta; 2015 Feb; 1852(2):290-8. PubMed ID: 25229693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.